about
Mitochondria control functional CaV1.2 expression in smooth muscle cells of cerebral arteriesSMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway20-Hydroxycholecalciferol, product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by increasing IkappaB alpha levels in human keratinocytes.Interferon-alpha selectively activates the beta isoform of protein kinase C through phosphatidylcholine hydrolysisReview of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.Corticotropin-releasing hormone inhibits nuclear factor-kappaB pathway in human HaCaT keratinocytes.Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells.IFN induces miR-21 through a signal transducer and activator of transcription 3-dependent pathway as a suppressive negative feedback on IFN-induced apoptosis.Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activityThe curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivoThe role of nuclear factor κB in the interferon responseContinuous local delivery of interferon-β stabilizes tumor vasculature in an orthotopic glioblastoma xenograft resection modelMicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancersMolecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells.CRH inhibits NF-kappa B signaling in human melanocytes.Role of interferon alpha/beta receptor chain 1 in the structure and transmembrane signaling of the interferon alpha/beta receptor complex.Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells.Liposome-encapsulated curcumin suppresses neuroblastoma growth through nuclear factor-kappa B inhibition.DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in miceMiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity.Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1.Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization.Interferon inhibits the redistribution of cell surface components.Interferon alpha induces protein kinase C-epsilon (PKC-epsilon) gene expression and a 4.7-kb PKC-epsilon-related transcriptDo second messengers play a role in interferon signal transduction?Structure of the human interferon alpha receptor.Transmembrane signalling by interferon-alpha.Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.Noncalcemic 20-hydroxyvitamin D3 inhibits human melanoma growth in in vitro and in vivo modelsNovel approaches to glioma drug design and drug screening.Chromenes: potential new chemotherapeutic agents for cancer.NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.Combining gene expression QTL mapping and phenotypic spectrum analysis to uncover gene regulatory relationships.MicroRNA regulation of F-box proteins and its role in cancer.The effects of type I interferon on glioblastoma cancer stem cells.KLF4 expression enhances the efficacy of chemotherapy drugs in ovarian cancer cells.
P50
Q24606272-8C9F9FDF-005F-4CA4-BEE1-774E57A5A8EEQ28831292-1637E064-1415-4958-93A8-C1DDBEA5B740Q33471485-82D9DF10-267C-4541-96FC-9A3F6535EA30Q33758233-861AE1A2-8167-496E-87F0-3A3DFBB84C15Q33941092-6F311A8E-83CC-4D9C-83FA-886C62C5BB83Q33947439-6DA38679-7AB7-4B7D-B27E-C0DE65993D60Q33997736-EBEC1EA1-940A-4F8F-9B72-2D15CFE06EABQ34049023-F37F02E2-E414-4E78-A50D-2C120F629C04Q34316477-ADAEB46E-6F92-4B22-8A16-7C154A6A40E0Q34461211-177210EA-C93B-4344-BE6D-6C6E25D982ADQ34585809-0BBCD40D-55E1-4E79-B1F9-3749CB12354CQ34936837-3B532C9D-F198-4B2A-9FA3-7DCDE8A21120Q35084134-92F3F211-5187-4F02-8618-96DDDE1141BCQ35190237-D3025CC6-D5AA-4580-AB05-CEA67E1EF1E2Q35519420-DD114825-DEEA-4B3A-A0F8-969684462198Q35587235-4C2C5038-AEBA-45B7-8914-F2DC5EB13F81Q35663864-08583277-0F5D-444E-A002-7314DBC69D51Q35723895-61B4E2EC-CB10-48C0-89D9-2047119EB6F3Q35800446-6717253B-F9C6-43EB-AE39-D1C9D3BC3B46Q35808662-825DB4E4-AE22-4D7E-AEF0-C1645E0F2078Q35903339-C408B84B-74E7-4673-BFA8-7BCD68292B21Q36003649-8ECE582C-3BD9-4E4B-9133-96C6E368BBAEQ36157026-D188D5C8-2579-4EBF-8B11-6D75AC46EF7AQ36172960-95293ED5-252D-48E2-8627-B7FBB9CA1AFFQ36210534-297EB56F-AADC-401C-A17E-EBB665B7DAB3Q36343950-7F8919F8-1B9D-49BC-A895-40E83BC497F5Q36441584-44CE2979-8599-4805-82AF-4EABA03092B2Q36695699-ED1606A2-362B-4CA1-AB5C-6FB3ED198967Q36722310-A079B482-1D09-464A-864A-BDFD86C6ABBFQ37053576-F5246307-6412-4224-8E6E-3B515956521BQ37151086-573D7F09-41DF-41DB-8BC7-5BE439514876Q37699535-294568D3-6B16-44BB-ACA1-4727CCA47BBBQ37706071-2D83F6AD-F8AE-49F5-85A1-2C708FC64208Q38112184-9ED4FB6F-F53E-4A06-8F2E-39E9207EB3E8Q38139094-9BF88E55-650F-4E96-85B6-DD9CEC344BEAQ38315256-E0D718A0-EF72-49BD-9432-BFD047761F20Q38518221-58636015-EF42-409B-9689-BC9AA4F57E89Q38577492-8F7B5FBB-B001-4C54-A579-B2A46FB6B04DQ38696718-83FC4802-20DD-4C4A-A08D-F1C705C7CC94Q38720284-1993C9E0-7ACE-4CCE-8020-B8991BC7423B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lawrence M Pfeffer
@ast
Lawrence M Pfeffer
@en
Lawrence M Pfeffer
@es
Lawrence M Pfeffer
@nl
type
label
Lawrence M Pfeffer
@ast
Lawrence M Pfeffer
@en
Lawrence M Pfeffer
@es
Lawrence M Pfeffer
@nl
prefLabel
Lawrence M Pfeffer
@ast
Lawrence M Pfeffer
@en
Lawrence M Pfeffer
@es
Lawrence M Pfeffer
@nl
P106
P1153
7004513339
P31
P496
0000-0003-2809-1234